Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT05008575 · UNKNOWN

Trial details

NCT number: NCT05008575
Sponsor: Xinqiao Hospital of Chongqing
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2021-12-23
Primary completion: 2022-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.